Generalized myasthenia gravis (gMG) affects most patients through a handful of well-characterized neuromuscular junction ...

Fred Locke, MD, Moffitt Cancer Center, explains why this hematologic cancer is such an attractive target for chimeric antigen ...

The American Gastroenterological Association (AGA) has released an updated clinical practice guideline on the prevention of ...

A study on the long-term safety of CAR T-cell therapy for B-cell lymphoma patients reveals a favourable safety profile with ...

为了突破这些困境，科学家们将目光投向了自然杀伤细胞（Natural killer cell，NK 细胞）。NK 细胞是人体免疫系统的重要成员，在癌症免疫监视中发挥着关键作用，能以抗原非依赖的方式清除癌细胞和癌症干细胞，而且不存在移植物抗宿主病（Graft-versus-host disease，GvHD）的风险，非常适合开发 “现货型” 癌症免疫疗法。但是，目前用于改造 NK 细胞的 CAR ...

Dr Annalisa Morgan reflects on new data on DMTs for RRMS that highlighted the potential of BTK inhibitors such as ...

Tremtelectogene empogeditemcel (trem-cel) may make gemtuzumab ozogamicin maintenance safer for patients with high-risk acute myeloid leukemia (AML), according to results of a phase 1/2 trial presented ...

Chimeric antigen receptor T-cell therapy improves not only lupus disease activity but also other related conditions that ...

Scientists may have unlocked a new milestone in cancer treatment. An individual who received CAR T-cell therapy has been in ...

Immuno-oncology and cell-based treatments, which harness the body's own immune system to combat illnesses like cancer, have ...

Artiva Biotherapeutics, Inc.’s ARTV share price has surged by 13.59%, which has investors questioning if this is right time ...

One of the pioneers of CAR T-cell therapy, Dr. Brentjens spoke with Becker's about what the new facility means for cancer innovation, as well as on how leaders across the U.S. can best integrate CAR T ...